XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue Recognition (Tables)
6 Months Ended
Mar. 29, 2019
Revenue from Contract with Customer [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The following table compares the reported Condensed Consolidated Statements of Income for the three and six month period ended March 29, 2019, to the balances had the previous revenue accounting guidance remained in effect (in thousands):
 
 
Three Months Ended March 29, 2019
 
 
As Reported
 
Adoption adjustments of ASC 606
 
Balances without adoption of ASC 606
 
 
 
 
 
 
 
Revenue
 
$
3,999,987

 
$
(91,583
)
 
$
3,908,404

Costs and Expenses:
 
 
 
 
 
 
Cost of services provided
 
3,639,959

 
(94,490
)
 
3,545,469

Depreciation and amortization
 
147,908

 
4,893

 
152,801

Selling and general corporate expenses
 
88,285

 

 
88,285

          Gain on sale of Healthcare Technologies
 
1,000

 

 
1,000

 
 
3,877,152

 
(89,597
)
 
3,787,555

Operating income
 
122,835

 
(1,986
)
 
120,849

Interest and Other Financing Costs, net
 
84,178

 

 
84,178

Income Before Income Taxes
 
38,657

 
(1,986
)
 
36,671

Provision for Income Taxes
 
9,347

 
(514
)
 
8,833

Net income
 
29,310

 
(1,472
)
 
27,838

Less: Net income (loss) attributable to noncontrolling interest
 
(43
)
 

 
(43
)
Net income attributable to Aramark stockholders
 
$
29,353

 
$
(1,472
)
 
$
27,881

 
 
Six Months Ended March 29, 2019
 
 
As Reported
 
Adoption adjustments of ASC 606
 
Balances without adoption of ASC 606
 
 
 
 
 
 
 
Revenue
 
$
8,265,336

 
$
(180,090
)
 
$
8,085,246

Costs and Expenses:
 
 
 
 
 
 
Cost of services provided
 
7,434,404

 
(183,197
)
 
7,251,207

Depreciation and amortization
 
298,629

 
7,899

 
306,528

Selling and general corporate expenses
 
192,415

 

 
192,415

          Gain on sale of Healthcare Technologies
 
(156,309
)
 

 
(156,309
)
 
 
7,769,139

 
(175,298
)
 
7,593,841

Operating income
 
496,197

 
(4,792
)
 
491,405

Interest and Other Financing Costs, net
 
167,155

 

 
167,155

Income Before Income Taxes
 
329,042

 
(4,792
)
 
324,250

Provision for Income Taxes
 
49,054

 
(1,241
)
 
47,813

Net income
 
279,988

 
(3,551
)
 
276,437

Less: Net income (loss) attributable to noncontrolling interest
 
(49
)
 

 
(49
)
Net income attributable to Aramark stockholders
 
$
280,037

 
$
(3,551
)
 
$
276,486

The following table compares the reported Condensed Consolidated Balance Sheet as of March 29, 2019, to the balances had the previous revenue accounting guidance remained in effect (in thousands):
 
 
March 29, 2019
 
 
As Reported
 
Adoption adjustments of ASC 606
 
Balances without adoption of ASC 606
ASSETS
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
195,387

 
$

 
$
195,387

Receivables, net
 
1,878,151

 

 
1,878,151

Inventories
 
400,269

 
344,953

 
745,222

Prepayments and other current assets
 
156,796

 

 
156,796

Total current assets
 
2,630,603

 
344,953

 
2,975,556

Property and Equipment, net
 
2,142,944

 
(795,096
)
 
1,347,848

Goodwill
 
5,522,552

 

 
5,522,552

Other Intangible Assets
 
2,087,641

 

 
2,087,641

Other Assets
 
1,327,074

 
339,781

 
1,666,855

 
 
$
13,710,814

 
$
(110,362
)
 
$
13,600,452

LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
Current maturities of long-term borrowings
 
$
56,339

 
$

 
$
56,339

Accounts payable
 
911,785

 

 
911,785

Accrued expenses and other current liabilities
 
1,342,981

 
(23,526
)
 
1,319,455

Total current liabilities
 
2,311,105

 
(23,526
)
 
2,287,579

Long-Term Borrowings
 
7,134,286

 

 
7,134,286

Deferred Income Taxes and Other Noncurrent Liabilities
 
1,021,749

 
(23,544
)
 
998,205

Redeemable Noncontrolling Interest
 
9,994

 

 
9,994

Stockholders' Equity:
 
 
 
 
 
 
                   Common stock
 
2,812

 

 
2,812

Capital surplus
 
3,180,943

 

 
3,180,943

Retained earnings
 
992,736

 
(63,292
)
 
929,444

Accumulated other comprehensive loss
 
(141,651
)
 

 
(141,651
)
Treasury stock
 
(801,160
)
 

 
(801,160
)
Total stockholders' equity
 
3,233,680

 
(63,292
)
 
3,170,388

 
 
$
13,710,814

 
$
(110,362
)
 
$
13,600,452

Disaggregation of Revenue
The following table presents revenue disaggregated by revenue source (in millions):
 
 
Three Months Ended
 
Six Months Ended
 
 
March 29, 2019
 
March 29, 2019
FSS United States:
 
 
 
 
    Business & Industry
 
$
394.8

 
$
794.7

    Education
 
901.6

 
1,917.9

    Healthcare
 
221.4

 
484.7

    Sports, Leisure & Corrections
 
504.7

 
1,099.0

    Facilities & Other
 
394.5

 
781.0

         Total FSS United States
 
$
2,417.0

 
$
5,077.3

 
 
 
 
 
FSS International:
 
 
 
 
    Europe
 
512.0

 
1,032.2

    Rest of World
 
430.0

 
863.0

          Total FSS International
 
$
942.0

 
$
1,895.2

 
 
 
 
 
Uniform
 
$
641.0

 
$
1,292.8

 
 
 
 
 
Total Revenue
 
$
4,000.0

 
$
8,265.3

Contract with Customer, Asset and Liability
Below is a summary of the changes (in millions):
 
 
Balance, September 28, 2018
 
Add: Net increase in current period deferred income
 
Less: Recognition of deferred income
 
Balance, March 29, 2019
Deferred income
 
$
281.5

 
628.5

 
(676.4
)
 
$
233.6